Journal article
Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel
Abstract
Despite the challenges of the pandemic, there has been substantial progress with coronavirus disease 2019 (COVID-19) therapies. Pivotal COVID-19 trials like SOLIDARITY, RECOVERY, and ACCT-1 were rapidly conducted and data disseminated to support effective therapies. However, critical shortcomings remain on trial conduct, dissemination and interpretation of study results, and regulatory guidance in pandemic settings. The lessons that we learned …
Authors
Bhimraj A; Morgan RL; Shumaker AH; Baden L; Cheng VC-C; Edwards KM; Gandhi RT; Gallagher JC; Muller WJ; O’Horo JC
Journal
Clinical Infectious Diseases, Vol. 74, No. 9, pp. 1691–1695
Publisher
Oxford University Press (OUP)
Publication Date
May 3, 2022
DOI
10.1093/cid/ciab882
ISSN
1058-4838